食管非环周内镜黏膜下剥离术后狭窄的预测因素及术后即刻单剂曲安奈德注射
这项单中心前瞻性研究纳入203例接受食管内镜黏膜下剥离术(ESD)并局部注射曲安奈德(TA)的患者,用多因素分析寻找术后狭窄的独立预测因素。结果发现残留黏膜宽度≤5 mm、6~10 mm、放化疗史及颈段或上胸段食管肿瘤为独立预测因素;高危组狭窄率52.5%(31/59),低危组6.3%(9/144)。作者认为局部TA注射对低危患者可预防狭窄,对高危患者不足以预防狭窄,应考虑追加干预。
要点
- 残留黏膜宽度≤5 mm者狭窄风险最高(OR 29.0),6~10 mm者风险亦升高(OR 3.7)。
- 放化疗史(OR 5.1)与颈段或上胸段食管肿瘤(OR 3.8)亦为独立预测因素。
- 高危组狭窄率52.5%(31/59),低危组6.3%(9/144),高危患者应考虑追加干预。
核心结论
- 本研究识别出食管ESD并局部TA注射后狭窄的预测因素。
- 局部TA注射在低危患者中可预防ESD后狭窄,但在高危患者中不足以预防狭窄。
- 作者认为高危患者应考虑追加干预。
研究设计与样本
- 单中心前瞻性研究,纳入接受食管ESD并局部TA注射、且全面评估病变与ESD相关因素的患者。
- 共203例患者纳入分析,采用多因素分析识别狭窄的预测因素。
- 研究注册号:University Hospital Medical Network Clinical Trials Registry UMIN 000028894。
主要发现
- 多因素分析显示,残留黏膜宽度≤5 mm(OR 29.0;P < .0001)为独立预测因素。
- 残留黏膜宽度6~10 mm(OR 3.7;P = .04)为独立预测因素。
- 放化疗史(OR 5.1;P = .045)为独立预测因素。
- 颈段或上胸段食管肿瘤(OR 3.8;P = .018)为独立预测因素。
- 高危组(残留黏膜宽度≤5 mm,或6~10 mm且伴其他预测因素)狭窄率为52.5%(31/59例);低危组(残留黏膜宽度≥11 mm,或6~10 mm且无其他预测因素)狭窄率为6.3%(9/144例)。
关键数值与推荐
- 原文报告局部TA注射后仍有高达45%的患者发生狭窄。
- 高危组定义:残留黏膜宽度≤5 mm,或6~10 mm且伴其他预测因素。
- 低危组定义:残留黏膜宽度≥11 mm,或6~10 mm且无其他预测因素。
临床怎么用
- 作者认为,对于低危患者,局部TA注射可预防ESD后狭窄。
- 作者认为,对于高危患者,局部TA注射不足以预防狭窄,应考虑追加干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Local triamcinolone (TA) injection is widely used to prevent stricture formation after endoscopic submucosal dissection (ESD). However, stricture develops in up to 45% of patients despite this prophylactic measure. We therefore conducted a single-center prospective study to identify predictors of stricture after esophageal ESD and local TA injection. METHODS: Patients who underwent esophageal ESD and local TA injection and who were comprehensively assessed for lesion- and ESD-related factors were included in the study. Multivariate analyses were conducted to identify the predictors of stricture. RESULTS: A total of 203 patients were included in the analysis. Multivariate analysis identified residual mucosal width ≤5 mm (odds ratio [OR], 29.0; P < .0001) or 6 to 10 mm (OR, 3.7; P = .04), history of chemoradiotherapy (OR, 5.1; P = .045), and tumor in the cervical or upper thoracic esophagus (OR, 3.8; P = .018) as independent predictors of stricture. Based on the ORs of the predictors, patients were stratified into 2 groups according to stricture risk: patients in the high-risk group (residual mucosal width ≤5 mm or 6-10 mm with another predictor) had a stricture rate of 52.5% (31 of 59 cases), and patients in the low-risk group (residual mucosal width ≥11 mm or 6-10 mm without other predictors) had a stricture rate of 6.3% (9 of 144 cases). CONCLUSIONS: We identified predictors of stricture after ESD and local TA injection. Local TA injection prevented stricture formation after ESD in low-risk patients but was not sufficient to prevent stricture in high-risk patients. Additional interventions should thus be considered in high-risk patients. (University Hospital Medical Network Clinical Trials Registry number: UMIN 000028894.).
引用
- Miyake M, Ishihara R, Matsuura N, et al. Predictors of stricture after non-circumferential endoscopic submucosal dissection of the esophagus and single-dose triamcinolone injection immediately after the procedure. Gastrointest Endosc. 2023. PMID: 36990127. doi:10.1016/j.gie.2023.03.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。